BRIGHT-4 trial: bivalirudin strikes back. Piriou PG, Manigold T, Letocart V, Guerin P, et al. Lancet 2023;401:1157-1158.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Piriou PG, Manigold T, Letocart V, Guerin P, et al. BRIGHT-4 trial: bivalirudin strikes back. Lancet 2023;401:1157-1158.
PMID: 37030888